CLINICAL AND ECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICS CONSUMPTION BY PATIENTS WITH COVID-19

V. I. Petrov; N. Yu. Ryazanova; A. V. Ponomareva; O. V. Shatalova; Ya. V. Levina

Pharmacy & Pharmacology
Farmaciâ i farmakologiâ

ISSN 2307-9266 (Print)
ISSN 2413-2241 (Online)

User

eng | рус

Pharmacy & Pharmacology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Petrov V.I., Ryazanova N.Yu., Ponomareva A.V., Shatalova O.V., Levina Ya.V. CLINICAL AND ECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICS CONSUMPTION BY PATIENTS WITH COVID-19. Pharmacy & Pharmacology. 2022;10(2):198-206. https://doi.org/10.19163/2307-9266-2022-10-2-198-206

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2307-9266 (Print)
ISSN 2413-2241 (Online)

Editor-in-Chief

Petrov V.I.

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

V. I. Petrov
Volgograd State Medical University
Russian Federation

Doctor of Sciences (Medicine), Professor, Academician of RAS, Head of the Department of Clinical Pharmacology and Intensive Care of Volgograd State Medical University, chief freelance specialist, clinical pharmacologist of the Ministry of Healthcare of the Russian Federation, Honored Scientist of the Russian Federation, Honored Doctor of the Russian Federation